Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/28/2012 | CN102803228A Acid-labile trigger units |
11/28/2012 | CN102802682A Wound-covering material |
11/28/2012 | CN102802670A Stabilized proteases for use in skin care |
11/28/2012 | CN102802669A Hydrophobins for dispersing active agents |
11/28/2012 | CN102802668A Stabilised composition comprising at least one adrenergic compound |
11/28/2012 | CN102802657A GLP-1 and FGF21 combinations for treatment of diabetes type 2 |
11/28/2012 | CN102802642A Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
11/28/2012 | CN102802635A Anaesthetic formulation |
11/28/2012 | CN102802633A Method for improving bioavailability of latanoprost |
11/28/2012 | CN102802632A Pharmaceutical composition comprising a pyrimidineone derivative |
11/28/2012 | CN102802619A Ophthalmic composition |
11/28/2012 | CN102802612A Solid compositions comprising 5-aminolevulinic acid |
11/28/2012 | CN102802609A Stable nanoparticulate drug suspension |
11/28/2012 | CN102802605A Stabilized lipid formulation of apoptosis promoter |
11/28/2012 | CN102802604A Aqueous pharmaceutical compositions containing borate-polyol complexes |
11/28/2012 | CN102802438A Method for reducing unpleasant taste |
11/28/2012 | CN102796277A Gradient biocompatible polymer foaming material with opening structure and preparation method thereof |
11/28/2012 | CN102796235A Copolymer based on environmental response and preparation method thereof |
11/28/2012 | CN102796224A Multifunctional bionic polymer, its preparation method and application |
11/28/2012 | CN102796201A Erythropoietin mimetic peptide (EMP)-human serum albumin (HSA) fusion protein and preparation method thereof |
11/28/2012 | CN102796199A Fusion protein mutant of anti-cluster of differetiation (CD3) antibody Fv segment and interleukin 3, method for preparing fusion protein mutant and application of fusion protein mutant |
11/28/2012 | CN102796198A Fusion protein of anti-cluster of differetiation (CD3) antibody Fv segment and interleukin 3, method for preparing fusion protein and application of fusion protein |
11/28/2012 | CN102796197A Human serum albumin-granulocyte colony stimulating factor (HAS-GCSF) mutant and preparation method thereof |
11/28/2012 | CN102796119A Cefpirome sulfate compound and composition thereof |
11/28/2012 | CN102796016A Stable crystal modifications of dotap chloride |
11/28/2012 | CN102793929A Method for preparing stable amorphous drug preparation |
11/28/2012 | CN102793928A Kidney targeting medicament carrier and application thereof |
11/28/2012 | CN102793927A Swine fever vaccine heat-resistant freeze-drying protective agent, and preparation method and application thereof |
11/28/2012 | CN102793926A Edible jelly-form composition, jelly-form preparation and method for producing jelly-form preparation |
11/28/2012 | CN102793925A Medicinal premixing agent consisting of hydroxypropyl cellulose and lactose |
11/28/2012 | CN102793924A Medicinal premixing agent consisting of silicon dioxide and calcium hydrophosphate |
11/28/2012 | CN102793919A Pharmaceutical composition and method for producing the same |
11/28/2012 | CN102793879A Compound ointment for treating beriberi and foot odor |
11/28/2012 | CN102793839A Taste-modifying Chinese medicinal preparation and preparation method thereof |
11/28/2012 | CN102793787A Traditional Chinese medicine ointment for postoperative analgesia and wound healing promotion, and preparation method thereof |
11/28/2012 | CN102793782A Externally applied ointment for leucoderma |
11/28/2012 | CN102793740A Nutrient particles with auxiliary protecting function on chemical liver injury |
11/28/2012 | CN102793730A Ginkgo-damole medicinal composition and preparation method thereof |
11/28/2012 | CN102793720A Method for solving crystal substance precipitation of mixed sugar electrolyte injection after disinfection |
11/28/2012 | CN102793706A Preparation method of tolvaptan solid dispersion |
11/28/2012 | CN102793701A Lurasidone composition |
11/28/2012 | CN102793699A Medicinal composition containing dabigatran etexilate |
11/28/2012 | CN102793688A Method for preparing lactase nanocapsules |
11/28/2012 | CN102793686A Preparation method for empty capsule |
11/28/2012 | CN102793685A Oral capsule containing pregabalin and preparation method thereof |
11/28/2012 | CN102793684A Roflumilast liquid preparation and preparation method thereof |
11/28/2012 | CN102793683A Slow release composition containing levomilnacipran and preparation method of composition |
11/28/2012 | CN102793682A Rapid-release compound omeprazole tablet and preparation method thereof |
11/28/2012 | CN102793681A Benzimidazole derivative-containing solid medicinal composition |
11/28/2012 | CN102793680A Azilsartan solid dispersion and preparation method and medicinal composition thereof |
11/28/2012 | CN102793679A Roxatidine acetate hydrochloride freeze-dried powder injection as well as preparation method and applications thereof |
11/28/2012 | CN102793678A Method for preparing tween-free docetaxel injection |
11/28/2012 | CN102793676A Sesquiterpene lactone (1 beta, 10 beta-epoxy-13-alpha-dimethylamino-1,2-propanediol 3-(4)-alkene-6,12-lactone) dimethylamine hydrochloride freeze-drying preparation for injection and preparation method for sesquiterpene lactone (1 beta, 10 beta-epoxy-13-alpha-dimethylamino-1,2-propanediol 3-(4)-alkene-6,12-lactone) dimethylamine hydrochloride freeze-drying preparation |
11/28/2012 | CN102793675A Rifapentine sustained-released microspheres and preparation method thereof |
11/28/2012 | CN102793674A Triptolide solid lipid nanoparticle as well as preparation method and application thereof |
11/28/2012 | CN102793673A Solid dispersion body of berberine-phospholipid complex and preparation method thereof |
11/28/2012 | CN102793672A Chitosan-modified methazolamide solid lipid nanoparticles and preparation method thereof |
11/28/2012 | CN102793671A Human recombinant epidermal growth factor (hrEGF)-modified cisplatin-loaded polymeric nanoparticles and preparation method and application thereof |
11/28/2012 | CN102793670A PS (Phosphatidylserine)-liposome and synthesis process thereof |
11/28/2012 | CN102793669A PS-liposome synthesizing process |
11/28/2012 | CN102793668A PS (Phosphatidylserine)-liposome |
11/28/2012 | CN102793664A Sodium aescinate micro-emulsification injection and preparation method thereof |
11/28/2012 | CN102793663A Sustained-release microsphere injection containing antitumor drug (2-methoxyestradiol) |
11/28/2012 | CN102793661A A liquid product of botulinum a-type toxin |
11/28/2012 | CN102793629A Preparation method of rapidly disintegrating paper type dry paste tablets capable of rapidly disintegrating in oral cavity |
11/28/2012 | CN102792947A Cryopreservation liquid and injection of mesenchymal stem cells |
11/28/2012 | CN102423311B Sodium ozagrel injection solution and preparation method thereof |
11/28/2012 | CN102397237B Tilmicosin micelle preparation and preparation method thereof |
11/28/2012 | CN102389403B Freeze dried monophosphate adenine arabinoside powder injection for injection and preparation method thereof |
11/28/2012 | CN102343099B Preparation method and application of folacin mediated tumor targeting adriamycin prodrugs |
11/28/2012 | CN102319441B Preparation method of PLGA swine influenza DNA vaccine microsphere |
11/28/2012 | CN102319228B Dutasteride liquid hard capsule and preparation method thereof |
11/28/2012 | CN102304225B Polymer liposomes based on polyamino acid and quaternary ammonium salt and preparation method for polymer liposomes |
11/28/2012 | CN102295765B Copolycondensation synthesized polylactic acid-glycollic acid catalyzed by biomass creatinine |
11/28/2012 | CN102293755B Two lyophilized powder injections of methylprednisolone sodium succinate and preparation methods thereof |
11/28/2012 | CN102284062B Capsule shell composition for soft capsule containing ciclosporin, preparation method thereof and soft capsule containing ciclosporin prepared thereby |
11/28/2012 | CN102240406B Method for realizing surface modification of tumor targeted nonviral vector and application thereof |
11/28/2012 | CN102228433B Supersaturated self-microemulsion as well as preparation method and application thereof |
11/28/2012 | CN102144984B Easy-dissolution lamivudine tablet and preparation method thereof |
11/28/2012 | CN102144962B Powdered osletamirvir phosphate medicinal composition |
11/28/2012 | CN102125521B Paclitaxel emulsion, preparation method and application thereof |
11/28/2012 | CN102114006B Preparation method of chitosan hollow and core-shell microcapsule with pH-sensitive burst release property |
11/28/2012 | CN102085355B Liraglutide long-acting microsphere injection and preparation method thereof |
11/28/2012 | CN102008525B Pellet of celery seed extract and preparation method thereof |
11/28/2012 | CN101991595B Plasma substitute and preparation method thereof |
11/28/2012 | CN101954090B Dihydroartemisinin beta-cyclodextrin inclusion compound, preparation method thereof and antimalarialdrug with same |
11/28/2012 | CN101951896B Composite preparation |
11/28/2012 | CN101926777B Method for preparing vidarabine monophosphate for injection |
11/28/2012 | CN101920018B Pharmaceutic adjuvant and preparation method thereof |
11/28/2012 | CN101897677B Imperatorin sustained release tablets and preparation method thereof |
11/28/2012 | CN101862456B Remedy |
11/28/2012 | CN101854918B Nucleic acid complex and nucleic acid delivery composition |
11/28/2012 | CN101766722B Spray formula with slough-eliminating and granulation-promoting effects |
11/28/2012 | CN101703777B Tamper-resistant oral opioid agonist formulations |
11/28/2012 | CN101631804B Dextran functionalized with hydrophobic amino acids |
11/28/2012 | CN101617827B Supramolecular composite of isosteviol or derivative thereof and preparation method thereof |
11/28/2012 | CN101602791B Integrin receptor target lipidosome drug carrier, preparation method and application thereof |
11/28/2012 | CN101524537B Influenza oral tablet vaccine, influenza oral slow-release vaccine and preparation methods thereof |
11/28/2012 | CN101415442B Controlled release gels |
11/28/2012 | CN101384275B Dissolution aids for oral peptide delivery comprising a biguanide |